REGISTERED NUMBER: 03936112 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 December 2025

for

Jointmedica Limited

Page

Company Information

1

Chartered Accountants' Report

2

Balance Sheet

3

Notes to the Financial Statements

5

DIRECTOR:

Dr S K Kusuma

REGISTERED OFFICE:

Brook House

Moss Grove

Kingswinford

West Midlands

DY6 9HS

REGISTERED NUMBER:

03936112 (England and Wales)

ACCOUNTANTS:

Wilkes Tranter & Co Limited

Brook House

Moss Grove

Kingswinford

West Midlands

DY6 9HS

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Director's Report are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Jointmedica Limited for the year ended 31 December 2025 which comprise the Profit and Loss Account, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Jointmedica Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Jointmedica Limited and state those matters that we have agreed to state to the director of Jointmedica Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Jointmedica Limited and its director for our work or for this report.

It is your duty to ensure that Jointmedica Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Jointmedica Limited. You consider that Jointmedica Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Jointmedica Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Wilkes Tranter & Co Limited

Brook House

Moss Grove

Kingswinford

West Midlands

DY6 9HS

11 August 2026

FIXED ASSETS

Intangible assets

4

111,969

104,953

Tangible assets

5

801,884

607,665

Investments

6

57,754

57,754

971,607

770,372

CURRENT ASSETS

Stocks

1,183,748

1,024,482

Debtors

7

2,927,192

1,407,285

Cash at bank and in hand

17,590,785

11,022,963

21,701,725

13,454,730

CREDITORS

Amounts falling due within one year

8

(1,030,687

)

(1,148,736

)

NET CURRENT ASSETS

20,671,038

12,305,994

TOTAL ASSETS LESS CURRENT LIABILITIES

21,642,645

13,076,366

CAPITAL AND RESERVES

Called up share capital

35,898

25,854

Share premium

36,376,843

20,089,370

Capital contribution

4,674,000

4,674,000

Retained earnings

(19,444,096

)

(11,712,858

)

21,642,645

13,076,366

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 11 August 2026 and were signed by:

Dr S K Kusuma - Director

1.	STATUTORY INFORMATION

Jointmedica Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of twenty years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Improvements to property

-

at varying rates on cost

Plant and machinery

-

at varying rates on cost

Fixtures and fittings

-

at varying rates on cost

Computer equipment

-

at varying rates on cost

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 25 (2024 - 22 ) .

4.	INTANGIBLE FIXED ASSETS

Patents

and

licences

£

COST

At 1 January 2025

139,902

Additions

14,749

At 31 December 2025

154,651

AMORTISATION

At 1 January 2025

34,949

Amortisation for year

7,733

At 31 December 2025

42,682

NET BOOK VALUE

At 31 December 2025

111,969

At 31 December 2024

104,953

5.	TANGIBLE FIXED ASSETS

Improvements

Fixtures

to

Plant and

and

Computer

property

machinery

fittings

equipment

Totals

£

£

£

£

£

COST

At 1 January 2025

252,898

1,172,180

23,489

96,315

1,544,882

Additions

34,185

366,977

20,874

19,946

441,982

At 31 December 2025

287,083

1,539,157

44,363

116,261

1,986,864

DEPRECIATION

At 1 January 2025

42,253

810,084

10,605

74,275

937,217

Charge for year

56,432

157,094

11,711

22,526

247,763

At 31 December 2025

98,685

967,178

22,316

96,801

1,184,980

NET BOOK VALUE

At 31 December 2025

188,398

571,979

22,047

19,460

801,884

At 31 December 2024

210,645

362,096

12,884

22,040

607,665

6.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1 January 2025

and 31 December 2025

57,754

NET BOOK VALUE

At 31 December 2025

57,754

At 31 December 2024

57,754

7.

DEBTORS

2025

2024

£

£

Amounts falling due within one year:

Trade debtors

77,228

153,596

Other debtors

650,801

434,740

728,029

588,336

2025

2024

£

£

Amounts falling due after more than one year:

Amounts owed by group undertakings

2,199,163

818,949

Aggregate amounts

2,927,192

1,407,285

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade creditors

428,281

222,880

Taxation and social security

53,020

46,668

Other creditors

549,386

879,188

1,030,687

1,148,736

9.	ULTIMATE CONTROLLING PARTY

The company was under the control of its directors throughout the current and previous year.

The ultimate parent undertaking is TPG,INC registered in Delaware, United States by virtue of holding a controlling shareholding in the company.